Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBPbeta.
Article Details
- CitationCopy to clipboard
Shimizu M, Li J, Inoue J, Sato R
Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBPbeta.
PLoS One. 2015 Apr 15;10(4):e0121784. doi: 10.1371/journal.pone.0121784. eCollection 2015.
- PubMed ID
- 25875015 [ View in PubMed]
- Abstract
Quercetin is one of the most abundant polyphenolic flavonoids found in fruits and vegetables and has anti-oxidative and anti-obesity effects. Because the small intestine is a major absorptive organ of dietary nutrients, it is likely that highly concentrated food constituents, including polyphenols, are present in the small intestinal epithelial cells, suggesting that food factors may have a profound effect in this tissue. To identify novel targets of quercetin in the intestinal enterocytes, mRNA profiling using human intestinal epithelial Caco-2 cells was performed. We found that mRNA levels of some apolipoproteins, particularly apolipoprotein B (apoB), are downregulated in the presence of quercetin. On the exposure of Caco-2 cells to quercetin, both mRNA and protein levels of apoB were decreased. Promoter analysis of the human apoB revealed that quercetin response element is localized at the 5'-proximal promoter region, which contains a conserved CCAAT enhancer-binding protein (C/EBP)-response element. We found that quercetin reduces the promoter activity of apoB, driven by the enforced expression of C/EBPbeta. Quercetin had no effect on either mRNA or protein levels of C/EBPbeta. In contrast, we found that quercetin inhibits the transcriptional activity of C/EBPbeta but not its recruitment to the apoB promoter. On the exposure of Caco-2 cells to quercetin 3-O-glucuronide, which is in a cell-impermeable form, no notable change in apoB mRNA was observed, suggesting an intracellular action of quercetin. In vitro interaction experiments using quercetin-conjugated beads revealed that quercetin binds to C/EBPbeta. Our results describe a novel regulatory mechanism of transcription of apolipoprotein genes by quercetin in the intestinal enterocytes.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Quercetin CCAAT/enhancer-binding protein beta Protein Humans UnknownInhibitorDetails - Pharmaco-transcriptomics
Drug Drug Groups Gene Gene ID Change Interaction Chromosome Quercetin Experimental Investigational APOA1 335 downregulated Quercetin results in decreased expression of APOA1 mRNA 11q23.3 Quercetin Experimental Investigational APOB 338 downregulated Quercetin results in decreased expression of APOB mRNA 2p24.1 Quercetin Experimental Investigational MTTP 4547 downregulated Quercetin results in decreased expression of MTTP mRNA 4q23